Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Edwards Lifesciences Corp    EW

EDWARDS LIFESCIENCES CORP (EW)
Mes dernières consult.
Most popular
Rapport
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/13/2017 10/16/2017 10/17/2017 10/18/2017 10/19/2017 Date
108.25(c) 108.52(c) 110.05(c) 111.2(c) 112.03(c) Last
1 446 300 790 162 951 410 865 675 1 713 295 Volume
-1.77% +0.25% +1.41% +1.04% +0.75% Change
More quotes
Financials ($)
Sales 2017 3 392 M
EBIT 2017 1 030 M
Net income 2017 800 M
Finance 2017 282 M
Yield 2017 -
Sales 2018 3 732 M
EBIT 2018 1 176 M
Net income 2018 868 M
Finance 2018 692 M
Yield 2018 -
P/E ratio 2017 30,48
P/E ratio 2018 27,69
EV / Sales2017 6,89x
EV / Sales2018 6,15x
Capitalization 23 656 M
More Financials
Company
Edwards Lifesciences Corp. engages in the design, development, manufacture, and markets products to treat stage cardiovascular disease.It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World.Its products are categorized into three areas: Surgical... 
More about the company
Surperformance© ratings of Edwards Lifesciences Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on EDWARDS LIFESCIENCES CORP
10/11 EDWARDS LIFESCIENCES : To Host Earnings Conference Call On October 24, 2017
09/29 EDWARDS LIFESCIENCES : Federal Contracts Awarded by Federal Agencies in Iowa (Se..
09/28 EDWARDS LIFESCIENCES : An Application for the Trademark "QPID" Has Been Filed by..
09/26 EDWARDS LIFESCIENCES : Announces Key Events for PCR London Valves 2017
09/24 EDWARDS LIFESCIENCES : Announces Key Events For PCR London Valves 2017
09/14 EDWARDS LIFESCIENCES : An Application for the Trademark "INTRACLUDE" Has Been Fi..
09/13 EDWARDS LIFESCIENCES : Federal Contracts Awarded by Federal Agencies in Iowa (Se..
09/07 EDWARDS LIFESCIENCES : business Edwards Lifesciences completes $100 million reno..
09/01 EDWARDS LIFESCIENCES : to Present at 12th Annual Wells Fargo Healthcare Conferen..
08/31 EDWARDS LIFESCIENCES : completes $100 million renovations of Irvine campus
More news
Sector news : Advanced Medical Equipment & Technology - NEC
10/17 European shares slip from highs as results, commodities weigh
10/16 Kobe Steel scandal latest to expose 'Made-in-Japan' fault-lines
10/11DJROYAL PHILIPS : Philips to Suspend Production of External Defibrillators at US F..
10/09 LafargeHolcim poaches Essilor's finance chief
10/09DJBOSTON SCIENTIFIC : Health-care Firms Used Radio, Social Media to Find Missing W..
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on EDWARDS LIFESCIENCES CORP 
EDWARDS LIFESCIENCES - 2016
Still a great upward potential
BUY
EDWARDS LIFESCIENCES  - 2015
Trading opportunity
BUY
More Strategies
Latest Tweets
10/18
1
10/17MPS Loria Financial Planners LLC Takes $140,000 Position in Edwards Lifescien.. 
10/17Zacks: Analysts Anticipate Edwards Lifesciences Corporation $EW Will Announce.. 
10/16Cowen and Company Reaffirms “Buy” Rating for Edwards Lifesciences Corporation.. 
10/16Contrasting Edwards Lifesciences Corporation $EW and ViewRay $VRAY  
More tweets
Qtime:79
News from SeekingAlpha
10/17 YOUR DAILY PHARMA SCOOP : Everybody's Gilead Problem, Halozyme's Further Progres..
10/15 Wedgewood Partners Q3'17 Client Letter - The Bull Market In Everything
10/09 First meeting of new FDA advisory committee this week
10/04 Edwards Lifesciences Is A Buy - Cramer's Lightning Round (10/3/17)
10/02 Right Time To Buy Medtronic? Know Why The Company Cannot Go Wrong In Cardiac ..
Chart EDWARDS LIFESCIENCES CORP
Duration : Period :
Edwards Lifesciences Corp Technical Analysis Chart | EW | US28176E1082 | 4-Traders
Technical analysis trends EDWARDS LIFESCIENCES CORP
Short TermMid-TermLong Term
TrendsNeutralBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 131 $
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Stanton J. Rowe Chief Scientific Officer & VP-Advanced Technology
John T. Cardis Independent Director
William J. Link Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
EDWARDS LIFESCIENCES CORP18.68%23 481
THERMO FISHER SCIENTIFIC INC.34.10%75 478
DANAHER10.55%59 778
BOSTON SCIENTIFIC CORPORATION36.48%40 505
INTUITIVE SURGICAL67.64%39 496
ROYAL PHILIPS20.07%38 649